How Can OPCs be Targeted for Therapeutic Interventions?
Research is ongoing to develop therapeutic strategies that target OPCs for the treatment of demyelinating diseases. Approaches include the use of pharmacological agents to promote OPC proliferation and differentiation, as well as cell-based therapies involving the transplantation of OPCs or their precursors. Additionally, understanding the signaling pathways and molecular mechanisms that regulate OPC function can lead to the identification of novel therapeutic targets.
